Skip to content

Semaglutide clinical trials: 210 trials

Page 3 of 5

  1. Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.

    NCT07242534 · Phase 4 · Recruiting

    Linked paper with results

  2. Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults

    NCT07513168 · Phase 4 · Recruiting

    Linked paper with results

  3. Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

    NCT07325435 · Phase 4 · Active, not recruiting

    Linked paper with results

  4. The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients

    NCT06243536 · Phase 4 · Status unknown

    Linked paper with results

  5. A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes

    NCT06894784 · Phase 3 · Recruiting

    Linked paper with results

  6. Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care

    NCT05205928 · Phase 2/3 · Completed

    Linked paper with results

  7. The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity

    NCT06489457 · Phase 3 · Completed

    Linked paper with results

  8. Once Weekly GLP-1 in Persons With Spinal Cord Injury

    NCT03292315 · Phase 4 · Completed

    Linked paper with results

  9. Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

    NCT02453711 · Phase 2 · Completed

    Posted results

  10. Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

    NCT05579977 · Phase 2 · Terminated

    Posted results

  11. Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

    NCT02461589 · Phase 2 · Completed

    Posted results

  12. Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes

    NCT01923181 · Phase 2 · Completed

    Posted results

  13. Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

    NCT05616013 · Phase 2 · Completed

    Posted results

  14. A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes

    NCT05144984 · Phase 2 · Completed

    Posted results

  15. Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

    NCT04971785 · Phase 2 · Completed

    Posted results

  16. A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide

    NCT00696657 · Phase 2 · Completed

    Posted results

  17. A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

    NCT04153929 · Phase 2 · Completed

    Posted results

  18. Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.

    NCT02970942 · Phase 2 · Completed

    Posted results

  19. A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus

    NCT04515849 · Phase 2 · Completed

    Posted results

  20. A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight

    NCT05486065 · Phase 2 · Completed

    Posted results

  21. Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity

    NCT06771115 · Phase 2 · Completed

    Posted results

  22. A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)

    NCT04944992 · Phase 2 · Completed

    Posted results

  23. A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity

    NCT04969939 · Phase 2 · Completed

    Posted results

  24. ADJUnct Semaglutide Treatment in Type 1 Diabetes

    NCT05537233 · Phase 2 · Completed

    Posted results

  25. Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)

    NCT03987074 · Phase 2 · Completed

    Posted results

  26. Effects of Semaglutide in HIV-Associated Lipohypertrophy

    NCT04019197 · Phase 2 · Active, not recruiting

    Posted results

  27. A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

    NCT04143945 · Phase 2 · Completed

    Posted results

  28. A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

    NCT04007107 · Phase 2 · Completed

    Posted results

  29. Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes

    NCT04982575 · Phase 2 · Completed

    Posted results

  30. A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage

    NCT03987451 · Phase 2 · Completed

    Posted results

  31. Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)

    NCT04216589 · Phase 2 · Completed

    Posted results

  32. Semaglutide for Alcohol Use Disorder

    NCT05520775 · Phase 2 · Completed

    Posted results

  33. Effects of Semaglutide on Nicotine Intake

    NCT05530577 · Phase 2 · Completed

    Posted results

  34. Semaglutide Use in Elderly Obese Patients

    NCT05302596 · Phase 2 · Completed

    Posted results

  35. Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

    NCT05016882 · Phase 2 · Completed

    Linked paper with results

  36. A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus

    NCT06256549 · Phase 2 · Status unknown

    Linked paper with results

  37. Semaglutide for Low Back Pain

    NCT07731256 · Phase 2 · Not yet recruiting

    Linked paper with results

  38. Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology

    NCT04451837 · Phase 2 · Active, not recruiting

    Linked paper with results

  39. Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes

    NCT05193578 · Phase 2 · Completed

    Linked paper with results

  40. Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies

    NCT05920889 · Phase 2 · Completed

    Linked paper with results

  41. A Study of CS060380 Tablets in Patients With MASH and Obesity

    NCT07466017 · Phase 2 · Active, not recruiting

    Linked paper with results

  42. Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?

    NCT05895643 · Phase 2 · Completed

    Linked paper with results

  43. COMMETS- Combination MCI Metabolic Syndrome

    NCT06072963 · Phase 2 · Recruiting

    Linked paper with results

  44. Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder

    NCT04466345 · Phase 2 · Completed

    Linked paper with results

  45. Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer

    NCT07820358 · Phase 2 · Not yet recruiting

    Linked paper with results

  46. GLP-1 RA for Stage 1 Type 1 Diabetes

    NCT07430332 · Phase 2 · Not yet recruiting

    Linked paper with results

  47. A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)

    NCT03951753 · Phase 1 · Completed

    Posted results

  48. GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight

    NCT04779697 · Phase 1 · Completed

    Posted results

  49. A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range

    NCT05671653 · Phase 1 · Terminated

    Posted results

  50. A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects

    NCT01037582 · Phase 1 · Completed

    Linked paper with results

How PepBank reports evidence